Skip to main content
Clinical Trials/NCT07584798
NCT07584798Not yet recruitingNot Applicable

Self-Monitoring Optical Coherence Tomography Device for Retinal Telehealth

Case Western Reserve University1 site in 1 country100 target enrollmentStarted: September 1, 2026Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100
Locations
1
Primary Endpoint
Positive predictive value (PPV) as measured by OCT images.

Study Overview

Brief Summary

The purpose of this research study is to test participants ability to obtain OCT images of the eyes using an OCT device that is comparable to FDA-approved OCT devices on the market, without the help of an eye technician. Patients with ocular diseases often need to come to frequent appointments with an eye care provider for close monitoring and evaluation. Transportation difficulties, other medical problems, and limited appointments slots can make regular follow-up challenging. In addition, the anxiety of permanent vision loss and subjective nature of monitoring symptoms highlight the need for an alternative solution in which patients can self-generate OCT images of the eye for the eye care provider to review.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 1. Provision of signed and dated informed consent.
  • 2. Age ≥ 18 years.
  • 3. Presenting for care at a University Hospitals Eye Institute clinic
  • 4. Willing to complete study questionnaires.
  • 5. Scheduled to undergo standard technician-acquired OCT

Exclusion Criteria

  • 1. Unable to provide informed consent or, in the judgment of study staff, unable to understand study procedures.
  • 2. Unable to cooperate with imaging or maintain stable positioning such that an evaluable OCT scan cannot be obtained (e.g., severe tremor or inability to maintain head position).
  • 3. Facial skin condition or open wound at the points of device contact that would make use of the headrest unsafe.
  • 4. Acute medical or ocular condition requiring immediate evaluation that, in the PI's judgment, precludes participation at that time.
  • 5. Any other condition that, in the opinion of the PI/designee, would place the participant at undue risk or compromise data quality (documented).
  • 6. Patients with visual acuity <20/
  • 7. Patients with significant media opacities precluding an OCT scan (posterior subcapsular cataract, vitreous hemorrhage, etc), or severe ptosis.

Arms & Interventions

Technician-acquired OCT

Active Comparator

Technicians will use a standard OCT device to obtain OCT images of the eyes as per standard of care.

Intervention: Technician-acquired OCT imaging (Procedure)

Self-administered OCT Images

Experimental

Participants will use an OCT device to obtain OCT images of the eyes.

Intervention: Self-administered OCT imaging system (Procedure)

Outcomes

Primary Outcomes

Positive predictive value (PPV) as measured by OCT images.

Time Frame: through study completion, an average of 1 year

Negative predictive value (NPV) as measured by OCT images.

Time Frame: through study completion, an average of 1 year

Number of inner retinal abnormalities detected as measured by OCT images

Time Frame: through study completion, an average of 1 year

Number of outer retinal abnormalities detected as measured by OCT images.

Time Frame: through study completion, an average of 1 year

Sensitivity as measured by OCT images.

Time Frame: through study completion, an average of 1 year

Specificity as measured by OCT images.

Time Frame: through study completion, an average of 1 year

Secondary Outcomes

  • Image-quality as recorded by nurse coordinator during patient interaction with the device.(through study completion, an average of 1 year)
  • Number of successful completion of self-scans as recorded by nurse coordinator during patient interaction with the device.(through study completion, an average of 1 year)
  • Number of repeated attempts(through study completion, an average of 1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Warren Sobol

Physician

Case Western Reserve University

Study Sites (1)

Loading locations...

Similar Trials